Discontinuation of first-line DMTs among patients with stable MS for at least 5 years may lead to an increased risk for recurrence.

The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...

Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

The microbiome in the gut comprises trillions of bacteria and other microorganisms that live in our digestive tracts, and are ...

The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has ...

Trishna Bharadia, Multiple Sclerosis (MS) patient advocate, talks about her goal to make MS care more patient-centric, ahead of her talk at the eyeforpharma Patient Summit Europe. Trishna Bharadia ...

Yale University study links gut microbiome changes to multiple sclerosis onset. Findings highlight differences in bacterial composition, IgA antibodies, and effects of B-cell depletion therapy.

A palliative care nurse who dedicates her life to looking after cancer patients has won the Ms Lancashire Galaxy title and is ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, ...